Cigna (0A77) Share Forecast & Price Target
0A77 Analyst Ratings
Moderate Buy
10Buy5Hold0Sell
Based on 15 analysts giving stock ratings to Cigna in the past 3 months
0A77 Stock 12 Month Forecast
Average Price Target
$338.13▲(13.25% Upside)Based on 15 Wall Street analysts offering 12 month price targets for Cigna in the last 3 months. The average price target is $338.13 with a high forecast of $387.00 and a low forecast of $290.00. The average price target represents a 13.25% change from the last price of $298.58.
Past 12 Months12 Month ForecastDec2025Sep2026
High$387.00
Average$338.13
Low$290.00
Highest Price TargetHighest$387.00Average Price Target$338.13Lowest Price TargetLowest$290.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Jessica Tassan | Piper Sandler | $370 | buy | 23.92%Upside | Reiterated | 10/23/26 | ||
| Ben Hendrix | RBC Capital | $337 | buy | 12.87%Upside | Reiterated | 10/07/26 | ||
| Lance Wilkes | Bernstein | $381→$387 | buy | 29.61%Upside | Reiterated | 10/05/26 | ||
| David S Macdonald | Truist Financial | $350 | buy | 17.22%Upside | Reiterated | 10/02/26 | ||
| Kevin Fischbeck | Bank of America Securities | $378 | buy | 26.60%Upside | Reiterated | 10/01/26 | ||
| Andrew Mok CFA | Barclays | $310 | hold | 3.82%Upside | Reiterated | 10/01/26 | ||
| Michael Wiederhorn | Oppenheimer | $365 | buy | 22.25%Upside | Reiterated | 10/01/26 | ||
 Unknown AnalystNot Ranked | Leerink Partners | $300 | hold | 0.48%Upside | Reiterated | 10/01/26 | ||
| Elizabeth Anderson CFA | Evercore ISI | $290 | hold | -2.87%Downside | Reiterated | 10/01/26 | ||
| Stephen Baxter | Wells Fargo | $307 | hold | 2.82%Upside | Reiterated | 09/30/26 | ||
| Charles Rhyee | TD Cowen | $338 | buy | 13.20%Upside | Reiterated | 09/30/26 | ||
| Erin Wright | Morgan Stanley | $361 | buy | 20.91%Upside | Reiterated | 09/29/26 | ||
| Parker Snure | Raymond James | $350→$320 | buy | 7.17%Upside | Reiterated | 08/03/26 | ||
| David Windley | Jefferies | $336→$307 | hold | 2.82%Upside | Downgraded | 08/03/26 | ||
| Scott Fidel | Goldman Sachs | $340→$352 | buy | 17.89%Upside | Reiterated | 08/02/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Jessica Tassan | 10/23/26 | $370 | buy | 23.92%Upside | Reiterated | Piper Sandler | ||
| Ben Hendrix | 10/07/26 | $337 | buy | 12.87%Upside | Reiterated | RBC Capital | ||
| Lance Wilkes | 10/05/26 | $381→$387 | buy | 29.61%Upside | Reiterated | Bernstein | ||
| David S Macdonald | 10/02/26 | $350 | buy | 17.22%Upside | Reiterated | Truist Financial | ||
| Kevin Fischbeck | 10/01/26 | $378 | buy | 26.60%Upside | Reiterated | Bank of America Securities | ||
| Andrew Mok CFA | 10/01/26 | $310 | hold | 3.82%Upside | Reiterated | Barclays | ||
| Michael Wiederhorn | 10/01/26 | $365 | buy | 22.25%Upside | Reiterated | Oppenheimer | ||
| Unknown AnalystNot Ranked | 10/01/26 | $300 | hold | 0.48%Upside | Reiterated | Leerink Partners | ||
| Elizabeth Anderson CFA | 10/01/26 | $290 | hold | -2.87%Downside | Reiterated | Evercore ISI | ||
| Stephen Baxter | 09/30/26 | $307 | hold | 2.82%Upside | Reiterated | Wells Fargo | ||
| Charles Rhyee | 09/30/26 | $338 | buy | 13.20%Upside | Reiterated | TD Cowen | ||
| Erin Wright | 09/29/26 | $361 | buy | 20.91%Upside | Reiterated | Morgan Stanley | ||
| Parker Snure | 08/03/26 | $350→$320 | buy | 7.17%Upside | Reiterated | Raymond James | ||
| David Windley | 08/03/26 | $336→$307 | hold | 2.82%Upside | Downgraded | Jefferies | ||
| Scott Fidel | 08/02/26 | $340→$352 | buy | 17.89%Upside | Reiterated | Goldman Sachs |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Cigna
3 Months
Success Rate17/27 ratings generated profit
63%
Average Return
+4.54%
Copying Ann Hynes's trades and holding each position for 3 Months would result in 62.96% of your transactions generating a profit, with an average return of +4.54% per trade.
1 Year
Success Rate25/32 ratings generated profit
78%
Average Return
+17.73%
Copying Scott Fidel's trades and holding each position for 1 Year would result in 78.13% of your transactions generating a profit, with an average return of +17.73% per trade.
2 Years
Success Rate30/32 ratings generated profit
94%
Average Return
+25.19%
Copying Scott Fidel's trades and holding each position for 2 Years would result in 93.75% of your transactions generating a profit, with an average return of +25.19% per trade.
0A77 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 25 | 30 | 21 | 24 | 18 |
| Hold | 4 | 7 | 5 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 29 | 37 | 26 | 31 | 25 |
In the current month, 0A77 has received 18 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. 0A77 average Analyst price target in the past 3 months is 338.13.
0A77 Financial Forecast
High$7.80
Consensus$7.52
Low$7.42
0A77 Earnings Forecast
Next quarter’s earnings estimate for 0A77 is $7.52 with a range of $7.42 to $7.80. The previous quarter’s EPS was $7.78. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High$74.3B
Consensus$72.6B
Low$70.5B
0A77 Sales Forecast
Next quarter’s sales forecast for 0A77 is $72.64B with a range of $70.51B to $74.28B. The previous quarter’s sales results were $71.60B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
0A77 Stock Forecast FAQ
What is GB:0A77’s average 12-month price target, according to analysts?
Based on analyst ratings, Cigna’s 12-month average price target is $338.13.
What is GB:0A77’s upside potential, based on the analysts’ average price target?
Cigna has 13.25% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Cigna a Buy, Sell or Hold?
Cigna has a consensus rating of Moderate Buy, which is based on 10 buy ratings, 5 hold ratings and 0 sell ratings.
What is Cigna’s share price target?
The average share price target for Cigna is $338.13. This is based on 15 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is $387.00, and the lowest forecast is $290.00. The average share price target represents a 13.25% increase from the current price of $298.58.
What do analysts say about Cigna?
Cigna’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Street analysts.
How can I buy shares of Cigna?
To buy shares of GB:0A77, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.